Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase mu.
Open Access
- 1 November 1992
- journal article
- research article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 98, 113-117
- https://doi.org/10.1289/ehp.9298113
Abstract
Several genes involved in the metabolism of carcinogens have been found to be polymorphic in human populations and are associated with increased risk of cancer at some sites. This study focuses on the polymorphic enzyme glutathione transferase mu (GT mu). Smokers with low lymphocyte GT mu activity are at an approximately 2-fold higher risk for lung cancer and an approximately 3-fold higher risk for stomach and colon adenocarcinomas. Recent cloning and sequencing of the GST1 gene has allowed the development of convenient genotyping methods based on restriction fragment length polymorphisms (RFLP) or the polymerase chain reaction (PCR). The GST1 polymorphism has been shown to be a deletion of the gene locus. To detect the presence or absence of the gene we amplified exons 4-5 and/or exons 6-7 of the GST1 gene by PCR. PCR amplification produced bands of 215-bp or 273-bp from individuals with one or two copies of the GST1 allele and no band if the individual was homozygously deleted (0/0). In the exon 6-7 PCR, we co-amplified a 268-bp portion of the beta-globin gene as an internal reference standard for quantitative analysis of product yield. This allowed homozygote individuals (+/+) to be distinguished from heterozygotes (+/0). We have compared the GST1 genotype to lymphocyte GT mu activity measured on trans-stilbene oxide (TSO) in the lymphocytes of 45 individuals. Low GT mu activity (< 67 pmole/min/10(7) cells) was strongly associated (24/24) with the GST1 0/0 genotype. With the exception of one individual, activities greater than 67 pmole/min/10(7) were associated with the presence of the GST1 allele (20/21). Individuals with the highest GT-TSO activity were found to be homozygous for GST1. (+/+), while heterozygotes (+/0) generally had lower activity, suggesting a gene dosage effect in lymphocytes.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 14 references indexed in Scilit:
- Glutathione S-transferase μ in human lymphocyte and liver: role in modulating formation of carcinogen-derived DNA adductsCarcinogenesis: Integrative Cancer Research, 1991
- Role of genetics and drug metabolism in human cancer riskMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
- Is environmental carcinogenesis modulated by host polymorphism?Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
- Polymerase chain reaction based assay to detect allelic loss in human DNA: loss of β-interleron gene in chronic myelogeneous leukemiaNucleic Acids Research, 1990
- GST1 gene deletion determined by polymerase chain reactionNucleic Acids Research, 1990
- Isoenzyme(S) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up studyCarcinogenesis: Integrative Cancer Research, 1990
- Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1988
- Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.Proceedings of the National Academy of Sciences, 1988
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988
- The hereditary transmission of high glutathione transferase activity towards trans-stilbene oxide in human mononuclear leukocytesHuman Genetics, 1985